Logo image of IVF

INVO FERTILITY INC (IVF) Stock Fundamental Analysis

USA - NASDAQ:IVF - US44984F7087 - Common Stock

0.55 USD
+0.01 (+2.08%)
Last: 11/10/2025, 8:00:02 PM
0.55 USD
0 (0%)
After Hours: 11/10/2025, 8:00:02 PM
Fundamental Rating

1

IVF gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. IVF has a bad profitability rating. Also its financial health evaluation is rather negative. IVF is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IVF has reported negative net income.
In the past year IVF has reported a negative cash flow from operations.
In the past 5 years IVF always reported negative net income.
In the past 5 years IVF always reported negative operating cash flow.
IVF Yearly Net Income VS EBIT VS OCF VS FCFIVF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of IVF (-145.93%) is worse than 86.24% of its industry peers.
IVF has a Return On Equity of -1071.38%. This is amonst the worse of the industry: IVF underperforms 87.30% of its industry peers.
Industry RankSector Rank
ROA -145.93%
ROE -1071.38%
ROIC N/A
ROA(3y)-109.72%
ROA(5y)-93.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVF Yearly ROA, ROE, ROICIVF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

IVF has a Gross Margin of 38.30%. This is in the lower half of the industry: IVF underperforms 68.25% of its industry peers.
IVF's Gross Margin has declined in the last couple of years.
IVF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.07%
GM growth 5Y-13.44%
IVF Yearly Profit, Operating, Gross MarginsIVF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

0

2. Health

2.1 Basic Checks

IVF does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IVF has more shares outstanding
Compared to 5 years ago, IVF has more shares outstanding
IVF has a worse debt/assets ratio than last year.
IVF Yearly Shares OutstandingIVF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K 200K
IVF Yearly Total Debt VS Total AssetsIVF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -8.30, we must say that IVF is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -8.30, IVF is not doing good in the industry: 74.60% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.73 indicates that IVF is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.73, IVF is not doing good in the industry: 70.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z -8.3
ROIC/WACCN/A
WACC5.63%
IVF Yearly LT Debt VS Equity VS FCFIVF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

IVF has a Current Ratio of 0.11. This is a bad value and indicates that IVF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.11, IVF is not doing good in the industry: 96.83% of the companies in the same industry are doing better.
A Quick Ratio of 0.10 indicates that IVF may have some problems paying its short term obligations.
IVF's Quick ratio of 0.10 is on the low side compared to the rest of the industry. IVF is outperformed by 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.1
IVF Yearly Current Assets VS Current LiabilitesIVF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

IVF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -734.90%.
The Revenue has grown by 14.84% in the past year. This is quite good.
IVF shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.57% yearly.
EPS 1Y (TTM)-734.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-614.52%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y16.23%
Revenue growth 5Y34.57%
Sales Q2Q%1.48%

3.2 Future

IVF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.59% yearly.
IVF is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.00% yearly.
EPS Next Y92.84%
EPS Next 2Y39.17%
EPS Next 3Y23.45%
EPS Next 5Y13.59%
Revenue Next Year10.02%
Revenue Next 2Y10.01%
Revenue Next 3Y10%
Revenue Next 5Y10%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IVF Yearly Revenue VS EstimatesIVF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2M 4M 6M 8M 10M
IVF Yearly EPS VS EstimatesIVF Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IVF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVF. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVF Price Earnings VS Forward Price EarningsIVF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVF Per share dataIVF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80

4.3 Compensation for Growth

IVF's earnings are expected to grow with 23.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.17%
EPS Next 3Y23.45%

More info and screens

0

5. Dividend

5.1 Amount

IVF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INVO FERTILITY INC

NASDAQ:IVF (11/10/2025, 8:00:02 PM)

After market: 0.55 0 (0%)

0.55

+0.01 (+2.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-17 2025-11-17
Inst Owners0.96%
Inst Owner Change151.98%
Ins Owners0.06%
Ins Owner Change0%
Market Cap2.40M
Revenue(TTM)6.62M
Net Income(TTM)-28.19M
Analysts80
Price Target18.36 (3238.18%)
Short Float %0.88%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.54%
Min Revenue beat(2)0.94%
Max Revenue beat(2)10.15%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-200%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-81.07
EYN/A
EPS(NY)-2.97
Fwd EYN/A
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-1.5
OCFYN/A
SpS1.52
BVpS0.6
TBVpS-1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -145.93%
ROE -1071.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.3%
FCFM N/A
ROA(3y)-109.72%
ROA(5y)-93.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.07%
GM growth 5Y-13.44%
F-Score3
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.82%
Cap/Sales 1.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.1
Altman-Z -8.3
F-Score3
WACC5.63%
ROIC/WACCN/A
Cap/Depr(3y)84.61%
Cap/Depr(5y)530.77%
Cap/Sales(3y)6.25%
Cap/Sales(5y)7.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-734.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-614.52%
EPS Next Y92.84%
EPS Next 2Y39.17%
EPS Next 3Y23.45%
EPS Next 5Y13.59%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y16.23%
Revenue growth 5Y34.57%
Sales Q2Q%1.48%
Revenue Next Year10.02%
Revenue Next 2Y10.01%
Revenue Next 3Y10%
Revenue Next 5Y10%
EBIT growth 1Y-68.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.88%
OCF growth 3YN/A
OCF growth 5YN/A

INVO FERTILITY INC / IVF FAQ

What is the ChartMill fundamental rating of INVO FERTILITY INC (IVF) stock?

ChartMill assigns a fundamental rating of 1 / 10 to IVF.


Can you provide the valuation status for INVO FERTILITY INC?

ChartMill assigns a valuation rating of 1 / 10 to INVO FERTILITY INC (IVF). This can be considered as Overvalued.


How profitable is INVO FERTILITY INC (IVF) stock?

INVO FERTILITY INC (IVF) has a profitability rating of 0 / 10.


What is the financial health of INVO FERTILITY INC (IVF) stock?

The financial health rating of INVO FERTILITY INC (IVF) is 0 / 10.